Blue Horseshoe Stocks: KO Review & More

The Coca-Cola Co. KO

Our first order of business today is to swing back around for our fresh Coke options trading idea from yesterday morning. We knocked it out of the park once again, adding to a long train of recent successes with options ideas, particularly those related to big time earnings beats.

We called for tracking the KO Weekly $45-46 Calls and are pleased to report that big gains were available throughout the entire range.

$45 Calls – Range: .83-1.56 – Max Gain: 88%
$45.50 Calls – Range: .44-1.08 – Max Gain: 230%
$46 Calls – Range: .18-.63 – Max Gain: 288%
________

Fresh Ideas:
AMD Weekly $16.50-17 Calls
QCOM Weekly $62.50-64 Calls

UAA Weekly $21.50-23 Calls


Extended Watchlist:
YEXT, TRCH, CNHI, UA, SVU, BEAT, BTI, CATB

Blue Horseshoe Stocks: MULE is Kicking & More

MuleSoft, Inc. MULE

We try to include mentions of all sorts of stocks from nano-caps all the way up to the big boards, and there can be no doubt we’ve found success with plays across the entire spectrum.  Generally, when we catch a stock for a large gain over a short time period, it trades for pennies a share or less. However MULE is yet another example of a higher priced stock that we recently put on our radar, making a series of big jumps in just over a month.

When we initially tagged this play back on February 16th, it was trading as low as 28.51. After a very bullish month was followed up by another big spike this week, MULE has kicked its way all the way up to 42.40, an impressive increase of 49%

The move was catalyzed by yesterday’s announcement that the company would be acquired in full by Salesforce. Generally you don’t get a sustained push from a buyout, so we wouldn’t be surprised if the stock didn’t go much higher, but we’ll keep an eye peeled just in case.


Aytu BioScience, Inc. AYTU

We’re going to place AYTU on watch this morning as a potential bottom bounce play. The stock produced abnormally high volume yesterday along with a marginal spike in PPS.

As you can see on the chart below, AYTU saw a precipitous decline in February, and has been oversold all month long, yet still maintaining support in the low to mid .40′s. Indicators suggest the possibility of a recovery on the horizon, so we”ll go ahead and monitor the activity here in the days ahead.


Fresh Options Idea:

General Mills Inc. GIS – General Mills has been in trouble on the chart for quite some time, and despite it already being at 3-year lows, the stock is continuing to get crushed on the heels of a disappointing earnings report. Accordingly, we’re going to be tracking the GIS 04/20 $50-45 Puts.


Extended Watchlist:
AKAO, OHGI, CPST, PTI, CATB, TLGT, TEUM

Blue Horseshoe Stocks: WATT Recap & More

Energous Corp. WATT

On our premarket watchlists for both Wednesday and yesterday morning, has been WATT, which received some exciting news this week.

The company revealed that the FCC has granted consumer safety certification for its wireless charging technology, marking the first FCC approval for remote wireless charging, and opening the door to commercialization.

Its applications are plentiful, and the potential is high, and it’s showing on the chart. On Wednesday morning following our alert, the stock was trading for as little as 15.30, and at its high of day yesterday, the stock had reached 33.50. That represented a two-session swing of 119% as it set new all-time highs for volume two days in a row.

We will be very interested to continue tracking the story behind this huge turn of events for WATT.


Helios and Matheson Analytics, Inc. HMNY

We also would like to recap HMNY’s performance yesterday. We tagged this one as a bottom play and ended up timing the bounce with absolute precision.

The stock had been in an overall downtrend since the end of November, and yesterday, began what could be just the start of a more sustained recovery.

HMNY traded up from a low of 5.45 and went on to reach a high of 6.98, for a modest but respectable increase of 28% on the day. It happened on roughly three times the monthly average volume, and closed near the high of day, so we’ll definitely be on the lookout for momentum carryover.



INSYS Therapeutics, Inc. INSY

Just a quick reminder about the options idea we had for INSY recently. We already reported the solid gains we’ve witnessed in the INSY 01/19 $8 and $9 Calls on Wednesday morning, but given the current conditions on the chart, we’ll want to keep an eye peeled for further bullish activity in those contracts.


Extended Watchlist:
ADHC, AGTK, CATB, GENE, PGNX, PGLC, SMIT,

Blue Horseshoe Stocks: KOOL, TIF Recaps & More

Endocyte, Inc. ECYT

We initially took notice of ECYT on Monday morning just as the company announced it had completed a worldwide license for its prostate cancer treatment now moving into Phase-3 development.

The stock made a solid 130% rip from 1.63 to 3.75 that morning, but it was only just getting started. Yesterday morning the stock ran hard once again, reaching its peak at a new annual high of 6.55. That puts the total on our two-day observed increased of 302% while volume over the same period has been literally hundreds of times greater than the monthly average prior to Monday’s bombshell PR.


Tiffany & Co. TIF – Options Update

As we were just mentioning yesterday morning, we’ve been tracking the TIF 10/20 $92-93 Calls since the morning of September 28th. TIF stock has maintained its gradual ascent since that time, and with that, we’ve seen the potential gains made off of our ideas grow along with it.

The following ranges represent the lows from the 28th to the highs achieved during yesterday’s session:

$92 Calls – Range: 1.00-2.20 – Max Gain: 120%
$92.50 Calls – Range: .85-2.19  – Max Gain: 158%.
$93 Calls – Range: .83-2.15 – Max Gain: 159%


Cesca Therapeutics Inc. KOOL

After including KOOL in yesterday morning’s watchlist, we watched as the stock made a very nice intraday run on the chart with the help of some positive news.

The U.S. Patent and Trademark Office issued a Notice of Allowance on the company’s patent application for its proprietary method for separating target cells from blood, marrow, and other sources.

That prompted a solid boost from 3.96 to 6.44 on the day, marking an intraday push of 63% which was accompanied by the trading of 223X more shares than the monthly average!


Extended Watchlist:
CATB, RGSE, CAPR, ATNM, VKTX, MNKD, BIOP,  HTBX

Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

We took notice of ECYT yesterday morning during our routine premarket scan, and due to some abnormal activity, we decided to include it in the daily watchlist.

It turned out to be a splendid idea, with the stock ultimately recording a hugely bullish session. ECYT traded from its low of 1.63 just following the open, to its high of 3.75 just prior to the close. It worked out to a single-session rip of 130% and it came on over 180X the monthly average volume. The stock has also hit a new high of 6.07 in the premarket this morning, pushing our observed move in less than 24 hours to a whopping 272%

It was especially impressive because of the timing, which couldn’t have been any better. Prior to yesterday’s session the stock was stagnating for several months. The move was catalyzed primarily by the announcement of the completion of a worldwide license on the company’s prostate cancer treatment, which will be moving on to Phase III development. (>>View PR)


Rigel Pharmaceuticals, Inc. RIGL

Speaking of solidly-timed calls on pharma plays, we also caught RIGL and included it in yesterday’s premarket report. It didn’t see the type of move that the previously mentioned stock, but got off to a respectable start.

RIGL traded in a range from 2.85-3.42, a modest rise of 20%, but did so on nearly 17X the monthly average volume, and closed near its high of day. We’ll continue to observe this play to see if it can establish a sustained uptrend.


Capricor Therapeutics, Inc. CAPR

We were just updating our readers yesterday morning on the moves CAPR had made since we had alerted it onSeptember 20th from its low of 1.80.

What followed was another nice session for the stock, which ran to a new high of 4.25; a total increase of 136% in a span of just eight trading days.



Tiffany & Co. TIF – Options Update

We also want to quickly update readers on our TIF options ideas that we submitted on the morning of September 28th, the TIF 10/20 $92-93 Calls. The stock has been in a continuous bullish pattern since then, and those calls made some pretty nice gains in the process.

$92 Calls – Range: 1.00-2.13 – Max Gain: 113%
$92.50 Calls – Range: .85-1.74  – Max Gain: 105%.
$93 Calls – Range: .83-1.88 – Max Gain: 127%


Extended Watchlist:
ETRM, VICL, DMPI, TA, KOOL, CATB